Stryker (SYK) Stock Forecast & Price Target

$331.67

+4.23 (+1.29%)

(As of 07/26/2024 ET)

Stryker - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy
Based on 19 Analyst Ratings

Based on 19 Wall Street analysts who have issued ratings for Stryker in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 19 analysts, 4 have given a hold rating, and 15 have given a buy rating for SYK.

Consensus Price Target

$372.05
12.18% Upside

High Forecast	$406.00
Average Forecast	$372.05
Low Forecast	$315.00

According to the 19 analysts' twelve-month price targets for Stryker, the average price target is $372.05. The highest price target for SYK is $406.00, while the lowest price target for SYK is $315.00. The average price target represents a forecasted upside of 12.18% from the current price of $331.67.

Type	Current Forecast 7/28/23 to 7/27/24	1 Month Ago 6/28/23 to 6/27/24	3 Months Ago 4/29/23 to 4/28/24	1 Year Ago 7/28/22 to 7/28/23
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	15 Buy rating(s)	15 Buy rating(s)	10 Buy rating(s)	11 Buy rating(s)
Hold	4 Hold rating(s)	4 Hold rating(s)	3 Hold rating(s)	5 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$372.05	$370.58	$340.67	$307.71
Forecasted Upside	12.18% Upside	12.22% Upside	7.63% Upside	9.19% Upside

Get Stryker Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for SYK and its competitors with MarketBeat's FREE daily newsletter.

Ad Paradigm Press

Musk’s new company could top a trillion?

The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just released the details on what he’s calling Elon’s Project X-9840.

Click here to see the details because there’s not much time to prepare.

SYK Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

SYK Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Stryker Stock vs. The Competition

Type	Stryker	Medical Companies	S&P 500
Consensus Rating Score	2.79	2.72	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	12.18% Upside	3,123.46% Upside	9.18% Upside
News Sentiment Rating	Positive News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
7/15/2024	BTIG Research 2 of 5 stars		Boost Target	Buy ➝ Buy	$369.00 ➝ $372.00	+12.59%
7/15/2024	Morgan Stanley 3 of 5 stars		Boost Target	Equal Weight ➝ Equal Weight	$345.00 ➝ $350.00	+5.94%
7/2/2024	Evercore ISI 2 of 5 stars		Lower Target	Outperform ➝ Outperform	$370.00 ➝ $365.00	+9.59%
5/30/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Neutral	$372.00	+9.06%
5/22/2024	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Matson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy	$392.00	+18.60%
5/2/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$372.00 ➝ $376.00	+15.17%
Get the Latest News and Ratings for SYK and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Stryker and its competitors with MarketBeat's FREE daily newsletter.
5/1/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$364.00 ➝ $381.00	+16.55%
5/1/2024	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$348.00 ➝ $405.00	+24.47%
5/1/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$339.00 ➝ $351.00	+7.41%
5/1/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$375.00 ➝ $380.00	+17.10%
5/1/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$350.00 ➝ $375.00	+11.50%
5/1/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$367.00 ➝ $378.00	+12.39%
4/15/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$360.00 ➝ $386.00	+13.92%
4/11/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$365.00 ➝ $400.00	+15.82%
4/3/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$362.00 ➝ $406.00	+15.19%
1/31/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$330.00 ➝ $345.00	+2.05%
1/31/2024	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$360.00	+6.66%
9/5/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Neutral ➝ Buy	$310.00 ➝ $315.00	+10.74%
5/25/2023	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$285.00 ➝ $310.00	+13.74%
5/2/2023	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$260.00 ➝ $292.00	-0.78%
5/2/2023	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$285.00 ➝ $315.00	+5.04%
5/2/2023	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$320.00 ➝ $345.00	+15.04%
4/23/2023	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$275.00 ➝ $336.00	+10.69%
4/17/2023	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy	$290.00 ➝ $312.00	+6.94%
1/25/2023	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Sector Weight ➝ Sector Weight
12/14/2022	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$233.00 ➝ $283.00	+11.44%
7/28/2022	Edward Jones Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 05:55 AM ET.

SYK Forecast - Frequently Asked Questions

What is Stryker's forecast for 2024?: According to the research reports of 19 Wall Street equities research analysts, the average twelve-month stock price forecast for Stryker is $372.05, with a high forecast of $406.00 and a low forecast of $315.00.
Should I buy or sell Stryker stock right now?: 19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stryker in the last twelve months. There are currently 4 hold ratings and 15 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" SYK shares.
Does Stryker's stock price have much upside?: According to analysts, Stryker's stock has a predicted upside of 12.53% based on their 12-month stock forecasts.
Has Stryker been upgraded by Wall Street analysts recently?: Over the previous 90 days, Stryker's stock had 1 upgrade by analysts.
What analysts cover Stryker?: Stryker has been rated by research analysts at Barclays, BTIG Research, Evercore ISI, Morgan Stanley, Needham & Company LLC, Piper Sandler, Robert W. Baird, Roth Mkm, Stifel Nicolaus, The Goldman Sachs Group, UBS Group, and Wells Fargo & Company in the past 90 days.
Do Wall Street analysts like Stryker more than its competitors?: Analysts like Stryker more than other "medical" companies. The consensus rating score for Stryker is 2.79 while the average consensus rating score for "medical" companies is 2.72. Learn more on how SYK compares to other companies.